YourVaccx, a new type of cancer vaccine developed by ImmunSYS, is safe and shows promising effectiveness in patients with metastatic prostate cancer and other difficult-to-treat advanced solid tumors, a proof-of-concept study shows. Study findings were presented in a poster titled, “Regression of metastatic cancer and abscopal effects following in situ vaccination by cryosurgical tumor cell lysis and intratumoral immunotherapy: A case series,” at the American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting II,…
You must be logged in to read/download the full post.
The post Vaccine Shows Promise in Advanced Prostate Cancer, Proof-of-Concept Study Shows appeared first on BioNewsFeeds.